SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC

Position in RLAY — Relay Therapeutics, Inc.

CIK 1446179 BALA CYNWYD, PA

Position in RLAY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$366,248

-$98,992 QoQ

Shares Held

19,575

-64.4% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#165

of 256 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC holds $18,967,826 across 42 Biotechnology names. RLAY ranks #16 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	91,886	$5,257,716
2	NKTR	Nektar Therapeutics	20,177	$1,408,556
3	QURE	uniQure N.V.	15,042	$692,834
4	OLMA	Olema Pharmaceuticals, Inc.	55,121	$689,563
5	VKTX	Viking Therapeutics, Inc.	16,620	$648,346
6	NTLA	Intellia Therapeutics, Inc.	37,663	$637,257
7	HRMY	Harmony Biosciences Holdings, Inc.	17,322	$630,694
8	IMNM	Immunome Inc.	26,035	$551,681

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$366,248	19,575	-64.4%	Shares	Sole	2026-08-14
2025-12-31	$465,240	54,993	-54.3%	Shares	Sole	2026-02-17
2025-09-30	$627,819	120,272	-56.9%	Shares	Sole	2025-11-14
2025-06-30	$966,073	279,212	-21.6%	Shares	Sole	2025-08-14
2025-03-31	$933,152	356,165	+2.9%	Shares	Sole	2025-05-14
2024-12-31	$1,426,706	346,288	+548.0%	Shares	Sole	2025-02-14
2024-06-30	$348,441	53,442	+248.7%	Shares	Defined	2024-08-15
2024-03-31	$127,197	15,325	+23.6%	Shares	Defined	2024-05-07
2022-09-30	$277,410	12,401	+75.9%	Shares	Defined	2022-11-14
2022-03-31	$211,036	7,051	-3.4%	Shares	Defined	2022-05-16
2021-09-30	$230,169	7,300	-36.8%	Shares	Defined	2021-11-15
2021-03-31	$399,214	11,548	-63.8%	Shares	Defined	2021-05-17
2020-12-31	$1,324,517	31,870	-18.1%	Shares	Defined	2021-02-16
2020-09-30	$1,657,049	38,907	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.